GERALDINE HENWOOD - 05 Dec 2021 Form 4 Insider Report for Baudax Bio, Inc. (BXRX)

Role
President and CEO, Director
Signature
By: /s/ Richard Casten, Attorney-in-fact
Issuer symbol
BXRX
Transactions as of
05 Dec 2021
Net transactions value
-$3,204
Form type
4
Filing time
14 Dec 2021, 17:27:32 UTC
Previous filing
23 Sep 2021
Next filing
23 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BXRX Common Stock Tax liability $3,204 -9,155 -2.5% $0.3500 355,352 05 Dec 2021 Direct F1
holding BXRX Common Stock 20,000 05 Dec 2021 By spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.